These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 30892442)
1. An immunohistochemistry and histopathological study of ankaferd blood stopper in a rat model of cervical inflammation. Beyazit F; Buyuk B Rev Assoc Med Bras (1992); 2019 Feb; 65(2):183-190. PubMed ID: 30892442 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic and preventative effects of ankaferd blood stopper in an experimental necrotizing enterocolitis model. Buyuktiryaki M; Tayman C; Koyuncu I; Cakir U; Taskin Turkmenoglu T; Cakir E; Okur N Biomed Pharmacother; 2019 Feb; 110():105-110. PubMed ID: 30465999 [TBL] [Abstract][Full Text] [Related]
3. Demonstration of the histopathological and immunohistochemical effects of a novel hemostatic agent, Ankaferd Blood Stopper, on vascular tissue in a rat aortic bleeding model. Kandemir O; Buyukates M; Kandemir NO; Aktunc E; Gul AE; Gul S; Turan SA J Cardiothorac Surg; 2010 Nov; 5():110. PubMed ID: 21073754 [TBL] [Abstract][Full Text] [Related]
4. Hemostatic Efficacy and Histopathological Effects of Ankaferd Blood Stopper in an Experimental Rat Model of Cyclophosphamide-induced Hemorrhagic Cystitis. Kilic O; Akand M; Karabagli P; Piskin MM Urology; 2016 Aug; 94():313.e7-313.e13. PubMed ID: 27215482 [TBL] [Abstract][Full Text] [Related]
5. Percutaneous ankaferd injection to in vivo liver tissue in comparison to ethanol in an experimental rat model. Taş A; Köklü S; Beyazit Y; Karaca G; Astarcı HM; Akbal E; Koçak E; Topçu G; Haznedaroglu IC Clin Res Hepatol Gastroenterol; 2011 Sep; 35(8-9):549-53. PubMed ID: 21489900 [TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of Ankaferd Blood Stopper on caustic esophageal injuries: an experimental model. Akbal E; Köklü S; Karaca G; Astarci HM; Koçak E; Taş A; Beyazit Y; Topcu G; Haznedaroğlu IC Dis Esophagus; 2012 Apr; 25(3):188-94. PubMed ID: 21819483 [TBL] [Abstract][Full Text] [Related]
7. Effect of the plant-based hemostatic agent Ankaferd Blood Stopper® on the biocompatibility of mineral trioxide aggregate. Dinçol ME; Ozbas H; Yılmaz B; Ersev H; Gokyay S; Olgac V BMC Oral Health; 2016 Oct; 16(1):111. PubMed ID: 27724900 [TBL] [Abstract][Full Text] [Related]
8. Hemostatic efficacy of a traditional medicinal plant extract (Ankaferd Blood Stopper) in bleeding control. Sogut O; Erdogan MO; Kose R; Boleken ME; Kaya H; Gokdemir MT; Ozgonul A; Iynen I; Albayrak L; Dokuzoglu MA Clin Appl Thromb Hemost; 2015 May; 21(4):348-53. PubMed ID: 24057394 [TBL] [Abstract][Full Text] [Related]
9. The Role of Ankaferd Blood Stopper and Oxytocin as Potential Therapeutic Agents in Endometriosis: A Rat Model. Hortu I; Ozceltik G; Karadadas E; Erbas O; Yigitturk G; Ulukus M Curr Med Sci; 2020 Jun; 40(3):556-562. PubMed ID: 32681259 [TBL] [Abstract][Full Text] [Related]
10. TNF-α, IL-1β, and oxidative stress during fracture healing with or without ankaferd. Amanvermez R; Gunay M; Piskin A; Keles G; Tomak L Bratisl Lek Listy; 2013; 114(11):621-4. PubMed ID: 24236429 [TBL] [Abstract][Full Text] [Related]
11. The efficacy of Ankaferd Blood Stopper in heparin-induced hemostatic abnormality in a rat epistaxis model. Iynen I; Sogut O; Kose R Otolaryngol Head Neck Surg; 2011 Nov; 145(5):840-4. PubMed ID: 21750339 [TBL] [Abstract][Full Text] [Related]
12. Medicinal plant extract (Ankaferd Blood Stopper) application in deep tissue injuries in rats: histopathological investigation of the effect on regional and systemic tissues. Okumuş M; Yüksel KZ; Özbağ D; Çıralık H; Yılmaz Z; Gümüşalan Y; Bakan V; Kalender AM Ulus Travma Acil Cerrahi Derg; 2013 Jan; 19(1):1-7. PubMed ID: 23588971 [TBL] [Abstract][Full Text] [Related]
13. Efficiency of Ankaferd Blood Stopper used in bleeding control on intraabdominal adhesions formed postoperatively. Behçet AL; Kılıç H; Zengin S; Güler M; Taysi S; Yıldırım C; Sarı İ Clin Appl Thromb Hemost; 2014 Jul; 20(5):524-9. PubMed ID: 23288869 [TBL] [Abstract][Full Text] [Related]
14. Intraarticular Ankaferd blood stopper application increases cartilagedegeneration: an experimental study. Kaya İ; Gülabi D; Yilmaz M; Baş A; Çeçen GS; Şener N Turk J Med Sci; 2016 Jan; 46(1):236-40. PubMed ID: 27511359 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the hemostatic and histopathological effects of Ankaferd Blood Stopper in experimental liver injury in rats. Satar NY; Akkoc A; Oktay A; Topal A; Inan K Blood Coagul Fibrinolysis; 2013 Jul; 24(5):518-24. PubMed ID: 23399904 [TBL] [Abstract][Full Text] [Related]
16. Effects of Ankaferd on anastomotic healing of colon. Cancan G; Teksoz S; Aytac E; Arikan AE; Erman H; Uzun H; Ozden F; Aydin O; Ozcan M J Invest Surg; 2014 Feb; 27(1):1-6. PubMed ID: 23987308 [TBL] [Abstract][Full Text] [Related]
17. Effects of a new hemostatic agent Ankaferd Blood Stopper(®)on the intraocular tissues in rat model. Alpay A; Bektas S; Alpay A; Ugurbas SC; Evren C; Ugurbas SH Cutan Ocul Toxicol; 2012 Jun; 31(2):128-31. PubMed ID: 22034855 [TBL] [Abstract][Full Text] [Related]
18. Beneficial effects of Ankaferd Blood Stopper on dermal wound healing: an experimental study. Akalin C; Kuru S; Barlas AM; Kismet K; Kaptanoglu B; Demir A; Astarci HM; Ustun H; Ertas E Int Wound J; 2014 Feb; 11(1):64-8. PubMed ID: 22943603 [TBL] [Abstract][Full Text] [Related]
19. Comparison of microporous polysaccharide hemospheres and Ankaferd Blood Stopper in a rabbit epistaxis model. Yurttas V; Sereflican M; Terzi EH; Ozyalvaçlı G; Kazaz H Eur Arch Otorhinolaryngol; 2016 Apr; 273(4):933-8. PubMed ID: 26100031 [TBL] [Abstract][Full Text] [Related]
20. Protective effects of Ankaferd blood stopper on aspirin-induced oxidative mucosal damage in a rat model of gastric injury. Hasgul R; Uysal S; Haltas H; Akyol S; Yuksel Y; Gurel A; Armutcu F Toxicol Ind Health; 2014 Nov; 30(10):888-95. PubMed ID: 23114375 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]